
LeonaBio fell 40.0% from $4.60 to $2.76, behind the S&P 500's +11.0%. Its worst day was Sep 25 (−34.9%), and its low came Nov 17 at $2.76.
Nov 18, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
LeonaBio shares rose 62.3%, while the S&P 500 rose 0.5%.
+62.3%, the year's best day, on 60M shares, the year's heaviest volume · S&P 500 +0.5%
LeonaBio shares rose 34.2%, while the S&P 500 rose 0.3%.
+34.2% · S&P 500 +0.3%
Story events cover the past 12 months · Times ET
EPS of $-2.77 missed the $-1.27 estimate on $0.00 revenue.
−7.3% · S&P 500 −1.7%
LeonaBio closed at its highest level of the year, 153.9% above where the year started.
+6.3% · S&P 500 0.0%
EPS of $-1.73 beat the $-2.50 estimate on $0.00 revenue.
+2.6% · S&P 500 +0.8%
EPS of $-0.80 beat the $-1.47 estimate on $0.00 revenue.
−5.0% · S&P 500 −0.5%
LeonaBio shares fell 34.9%, while the S&P 500 rose 0.5%.
−34.9%, the year's worst day · S&P 500 +0.5%
EPS of $-0.89 missed the $-0.67 estimate on $0.00 revenue.
−14.6% · S&P 500 −1.0%
Where it ended: a close of $2.76 on Nov 17, 2026.
Nothing in the past 12 months.
All LONA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LONA and SPY from Benzinga historical bars. Not investment advice.